InnoTek Limited Completes S\$16 Million Share Placement – Key Details for Investors

Summary of Key Developments

• InnoTek Limited has completed a major share placement, issuing 24,600,372 new ordinary shares at S\$0.6506 per share.
• The total number of issued ordinary shares increases from 233,279,628 to 257,880,000, representing a significant 10.5% expansion of the share base.
• The placement raised approximately S\$16 million for the company.
• Lion Global Investors Limited (LGI), a well-known institutional investor and wholly-owned subsidiary of Oversea-Chinese Banking Corporation Limited (OCBC), is one of the end-placees in this exercise.
• The placement shares are scheduled to begin trading on the SGX Mainboard from 16 April 2026 at 9:00 a.m.
• Maybank Securities Pte. Ltd. acted as the Placement Agent for this transaction.

Detailed Analysis and Implications for Shareholders

The completion of this placement marks a significant milestone for InnoTek Limited and could have substantial implications for shareholders and investors. Here are the details investors should pay close attention to:

1. Strategic Capital Raising

The company successfully raised about S\$16 million via the issuance of 24,600,372 new shares at S\$0.6506 per share. This placement price may be seen as a benchmark for the company’s current valuation and could influence near-term trading sentiment. The capital raised is expected to strengthen InnoTek’s balance sheet and may be deployed for working capital, expansion, or strategic investments.

2. Notable Institutional Participation

Lion Global Investors Limited (LGI), an established institutional investor and a wholly-owned subsidiary of OCBC, has been allotted shares in this placement. It is notable that LGI is related to Bank of Singapore Limited, another principal banker of InnoTek. Importantly, LGI has confirmed that, apart from banking relationships, it is not an “interested person” under SGX Listing Rules. This institutional participation could be viewed positively by the market as a vote of confidence in the company’s prospects.

3. Share Dilution and Capital Structure Impact

The issuance increases the company’s share capital by around 10.5%. While this dilutes existing shareholdings, the inflow of new funds and the addition of a reputable institutional investor could counterbalance dilution concerns. Investors should monitor how the capital will be used and whether it leads to improved earnings and value creation.

4. Trading and Liquidity Update

The new shares will commence trading on the SGX Mainboard from 16 April 2026, at 9:00 a.m. This event may lead to increased trading liquidity and attention from the broader investment community.

5. Corporate Governance and Compliance

The company has highlighted that the placement shares are to be issued free from all encumbrances and will rank pari passu with existing shares, except for any entitlements with a record date before issuance. The company also confirmed compliance with all SGX Listing Manual requirements.

Important Shareholder Advisory

• Shareholders are advised to exercise caution when dealing in InnoTek shares. The announcement specifically cautions against taking any action which may be prejudicial to their interests, and recommends consulting with professional advisers in case of doubt.

Potential Impact on Share Price

This placement is a price-sensitive event due to the significant capital raised, the entry of a reputable institutional investor, and the increase in issued shares. Investors should watch for possible price movements as trading of the new shares begins and as the market digests the implications of the placement.

Official Statement

The announcement is issued by Lou Yiliang, Executive Director and CEO of InnoTek Limited, dated 15 April 2026.

Regulatory Note

The Placement Shares are prescribed capital markets products under the Securities and Futures Act of Singapore and are classified as Excluded Investment Products under relevant MAS Notices.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult professional advisers before making any investment decisions related to InnoTek Limited or its securities. No responsibility is accepted for any loss arising from reliance on the information provided herein.

View InnoTek Historical chart here